https://clarivate.com/life-sciences-healthcare/report/pforeu1015-biopharma-gram-negative-infections-in-the-cost-constrained-physician-payer-forum-eu5-2015/
Gram-Negative Infections in the Cost-Constrained | Physician & Payer Forum | EU5 | 2015 | Clarivate
Market Access Opportunities for Novel Therapies Targeting Multi-Drug-Resistant Pathogens Hospital-treated Gram-negative infections (GNIs) are becoming...
gram negative infections
https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2021.748718/full
Frontiers | Discovering the Potentials of Four Phage Endolysins to Combat Gram-Negative Infections
Endolysin-based therapeutics are promising antibacterial agents and can successfully supplement the existing antibacterial drugs array. It is specifically im...